NASDAQ:PROF
Profound Medical Corp.
- Stock
Last Close
10.31
09/05 19:59
Market Cap
257.25M
Beta: 1.26
Volume Today
10.78K
Avg: 24.14K
PE Ratio
−6.25
PFCF: −8.27
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -0.00 - | 155.06K 31,061,696,967,600.01% | 724.11K 366.99% | 1.90M 162.70% | 3.16M 65.96% | 4.49M 42.20% | 6.37M 41.94% | 7.68M 20.48% | 7.46M 2.76% | ||
average payables | 4.59K - | 658.96K 14,252.06% | 2.68M 306.63% | 3.46M 29.01% | 2.94M 14.90% | 3.20M 8.66% | 3.28M 2.64% | 2.61M 20.56% | 2.66M 1.96% | ||
average receivables | 783.42K - | 292.94K 62.61% | 1.98M 577.01% | 2.95M 48.66% | 2.81M 4.77% | 5.36M 90.94% | 4.42M 17.52% | 3.88M 12.29% | 6.82M 75.76% | ||
book value per share | 6.31 - | 4.25 32.71% | 2.66 37.41% | 1.83 31.13% | 1.95 6.32% | 1.29 33.86% | 5.63 337.07% | 3.94 30.02% | 2.50 36.45% | ||
capex per share | -0.28 - | -0.05 82.03% | -0.19 283.45% | -0.06 69.12% | -0.02 - | -0.02 17.32% | -0.03 43.17% | ||||
capex to depreciation | -0.72 - | -1.40 94.38% | -5.81 314.32% | -0.53 90.83% | -0.12 - | -0.23 83.31% | -0.32 38.68% | ||||
capex to operating cash flow | 0.02 - | 0.02 14.37% | 0.07 207.93% | 0.03 58.27% | 0.01 - | 0.02 36.30% | 0.03 55.90% | ||||
capex to revenue | -0.09 - | -0.05 - | -0.05 5.95% | -0.09 80.05% | |||||||
cash per share | 6.79 - | 6.24 8.02% | 3.73 40.20% | 1.44 61.49% | 2.24 56.07% | 1.33 40.90% | 4.85 265.81% | 3.28 32.37% | 2.24 31.76% | ||
days of inventory on hand | 172.27 - | 745.31 332.63% | 736.31 1.21% | 508.05 31.00% | 690.07 35.83% | 791.93 14.76% | 905.57 14.35% | ||||
days payables outstanding | 611.71 - | 802.93 31.26% | 607.83 24.30% | 322.31 46.97% | 296.02 8.16% | 202.74 31.51% | 425.25 109.75% | ||||
days sales outstanding | 334.27 - | 444.08 32.85% | 283.82 36.09% | 371.35 30.84% | 74.99 79.81% | 346.59 362.20% | 369.51 6.61% | ||||
debt to assets | 1.89 - | 0.28 85.40% | 0.28 1.52% | 0.18 34.13% | 0.26 39.17% | 0.36 42.10% | 0.02 95.61% | 0.02 0.96% | 0.13 705.07% | 0.18 41.56% | |
debt to equity | 2.03 - | 0.42 79.39% | 0.45 6.84% | 0.36 18.68% | 0.45 23.41% | 0.76 70.03% | 0.02 97.74% | 0.02 0.79% | 0.16 826.53% | 0.25 60.93% | |
dividend yield | |||||||||||
earnings yield | -3.79 - | -0.50 86.84% | -0.29 41.27% | -0.24 16.70% | -0.28 13.26% | -0.09 65.78% | -0.06 35.64% | -0.13 118.54% | -0.13 2.64% | ||
enterprise value | 3.48M - | 20.31M 484.54% | 30.95M 52.35% | 56.67M 83.09% | 41.46M 26.83% | 159.84M 285.48% | 273.44M 71.07% | 165.30M 39.55% | 183.36M 10.92% | -18.27M 109.97% | |
enterprise value over ebitda | -0.56 - | -2.16 284.94% | -2.72 25.63% | -4.28 57.56% | -3.13 26.92% | -12.09 286.04% | -16.44 36.00% | -5.82 64.61% | -7.20 23.72% | 0.70 109.77% | |
ev to operating cash flow | -1.21 - | -4.11 240.44% | -2.87 30.20% | -4.80 67.24% | -3.09 35.65% | -10.42 237.66% | -13.29 27.50% | -7.39 44.38% | -7.11 3.87% | 0.82 111.53% | |
ev to sales | 14.53 - | 21.70 49.38% | 37.77 74.05% | 37.44 0.89% | 24.05 35.76% | 27.44 14.11% | -2.54 109.25% | ||||
free cash flow per share | -13.57 - | -2.14 84.24% | -2.79 30.68% | -1.98 29.00% | -1.34 32.56% | -1.40 4.59% | -1.21 13.54% | -1.12 7.30% | -1.24 10.73% | ||
free cash flow yield | -1.36 - | -0.21 84.24% | -0.28 30.68% | -0.20 29.00% | -0.24 22.61% | -0.09 61.00% | -0.06 37.99% | -0.10 68.85% | -0.12 17.19% | ||
graham net net | 11.08 - | 4.11 62.92% | 2.26 45.08% | 0.19 91.68% | 1.09 482.64% | 0.31 71.92% | 4.91 1,498.74% | 3.21 34.55% | 2.06 35.84% | ||
graham number | 73.35 - | 21.82 70.24% | 13.23 39.37% | 10.02 24.26% | 8.16 18.62% | 6.35 22.10% | 12.58 98.04% | 11.53 8.37% | 8.82 23.54% | ||
income quality | 0.35 - | 0.42 19.38% | 0.89 112.03% | 0.79 11.15% | 0.88 11.65% | 0.99 12.58% | 0.95 4.08% | 0.73 23.45% | 0.90 23.55% | 0.78 13.28% | |
intangibles to total assets | 0.02 - | 0.00 93.55% | 0.01 622.84% | 0.31 2,666.46% | 0.16 48.01% | 0.17 5.02% | 0.04 73.88% | 0.05 8.64% | 0.01 77.79% | 0.01 5.72% | |
interest coverage | -30.34 - | -2.77 90.87% | -25.40 817.29% | -16.45 35.24% | -19.63 19.36% | -27.78 41.53% | -34.74 25.05% | -99.97 187.78% | -170.13 70.18% | -37.16 78.16% | |
interest debt per share | 13.49 - | 3.49 74.12% | 1.34 61.67% | 0.84 37.16% | 0.95 12.92% | 1.03 8.72% | 0.13 87.57% | 0.08 36.02% | 0.40 392.81% | ||
inventory turnover | 2.12 - | 0.49 76.89% | 0.50 1.22% | 0.72 44.93% | 0.53 26.38% | 0.46 12.86% | 0.40 12.55% | ||||
invested capital | 2.03 - | 0.42 79.39% | 0.45 6.84% | 0.36 18.68% | 0.45 23.41% | 0.76 70.03% | 0.02 97.74% | 0.02 0.79% | 0.16 826.53% | 0.25 60.93% | |
market cap | 2.17M - | 23.68M 993.05% | 41.51M 75.27% | 61.40M 47.93% | 55.22M 10.08% | 163.65M 196.37% | 355.68M 117.35% | 231.08M 35.03% | 221.65M 4.08% | ||
net current asset value | 1.37M - | 9.87M 621.68% | 10.13M 2.63% | 3.07M 69.68% | 13.21M 330.02% | 7.08M 46.45% | 90.49M 1,178.94% | 70.97M 21.57% | 49.61M 30.10% | 29.16M 41.21% | |
net debt to ebitda | -0.21 - | 0.36 269.54% | 0.93 158.51% | 0.36 61.39% | 1.04 189.91% | 0.29 72.28% | 4.94 1,617.21% | 2.32 53.18% | 1.50 35.08% | 0.70 53.19% | |
net income per share | -37.86 - | -4.98 86.84% | -2.93 41.27% | -2.44 16.70% | -1.52 37.71% | -1.39 8.24% | -1.25 10.27% | -1.50 19.98% | -1.38 8.00% | ||
operating cash flow per share | -13.29 - | -2.09 84.29% | -2.60 24.53% | -1.92 25.99% | -1.34 30.45% | -1.38 3.31% | -1.19 13.93% | -1.09 8.16% | -1.24 13.67% | ||
payables turnover | 0.60 - | 0.45 23.82% | 0.60 32.10% | 1.13 88.59% | 1.23 8.88% | 1.80 46.01% | 0.86 52.32% | ||||
receivables turnover | 1.09 - | 0.82 24.73% | 1.29 56.47% | 0.98 23.57% | 4.87 395.22% | 1.05 78.36% | 0.99 6.20% | ||||
research and ddevelopement to revenue | 1.97 - | 3.94 100.74% | 2.26 42.83% | 1.36 39.83% | 2.22 63.79% | 2.20 1.08% | 2.00 9.17% | ||||
return on tangible assets | -5.71 - | -0.77 86.45% | -0.70 9.97% | -0.97 39.75% | -0.53 45.51% | -0.62 17.07% | -0.22 65.20% | -0.37 71.83% | -0.45 21.09% | -0.66 46.29% | |
revenue per share | 0.64 - | 0.19 70.04% | 0.38 100.42% | 0.42 10.73% | 0.34 20.48% | 0.32 4.24% | |||||
roe | -6.00 - | -1.17 80.44% | -1.10 6.16% | -1.33 20.95% | -0.78 41.41% | -1.08 38.74% | -0.22 79.47% | -0.38 71.45% | -0.55 44.77% | -0.92 66.20% | |
roic | -1.10 - | -0.75 31.58% | -0.98 30.16% | -1.15 17.76% | -0.53 54.13% | -0.57 6.83% | -0.19 66.80% | -0.36 94.22% | -0.49 33.82% | -0.71 46.14% | |
sales general and administrative to revenue | 1.21 - | 2.56 111.38% | 1.39 45.69% | 1.04 25.44% | 1.50 44.89% | 1.42 5.59% | 1.27 10.11% | ||||
shareholders equity per share | 6.31 - | 4.25 32.71% | 2.66 37.41% | 1.83 31.13% | 1.95 6.32% | 1.29 33.86% | 5.63 337.07% | 3.94 30.02% | 2.50 36.45% | ||
stock based compensation to revenue | 0.27 - | 0.42 52.96% | 0.30 27.32% | 0.41 36.21% | 1.05 153.71% | 0.63 39.49% | 0.47 25.17% | ||||
tangible asset value | 1.33M - | 10.04M 653.01% | 10.84M 8.01% | 4.45M 59.00% | 14.10M 217.17% | 9.28M 34.16% | 92.77M 899.36% | 76.49M 17.55% | 51.32M 32.90% | 30.69M 40.20% | |
tangible book value per share | 6.15 - | 4.24 31.11% | 2.61 38.38% | 0.72 72.28% | 1.40 93.99% | 0.84 40.42% | 5.36 541.10% | 3.74 30.32% | 2.47 33.90% | ||
working capital | 1.37M - | 14.17M 935.52% | 13.04M 7.94% | 5.47M 58.07% | 22.06M 303.31% | 14.50M 34.27% | 92.93M 541.05% | 72.97M 21.48% | 57.84M 20.74% | 35.53M 38.57% |
All numbers in USD (except ratios and percentages)